Generic placeholder image

Current Proteomics

Editor-in-Chief

ISSN (Print): 1570-1646
ISSN (Online): 1875-6247

Editorial

The Use of New Omics Techniques for Natural Products to Improve Drug Efficiency and Mechanism

In Press, (this is not the final "Version of Record"). Available online 28 May, 2024
Author(s): Khaled M.M. Koriem*
Published on: 28 May, 2024

DOI: 10.2174/0115701646320408240527081626

Price: $95

[1]
Koriem, K. Proteomic approach in human health and disease: Preventive and cure studies. Asian Pac. J. Trop. Biomed., 2018, 8(4), 226-236.
[http://dx.doi.org/10.4103/2221-1691.231285]
[2]
Koriem, K.M.M. Protective effect of natural products and hormones in colon cancer using metabolome: A physiological overview. Asian Pac. J. Trop. Biomed., 2017, 7(10), 957-966.
[http://dx.doi.org/10.1016/j.apjtb.2017.09.002]
[3]
Koriem, K.M.M. Lipidome is lipids regulator in gastrointestinal tract and it is a life collar in COVID-19: A review. World J. Gastroenterol., 2021, 27(1), 37-54.
[http://dx.doi.org/10.3748/wjg.v27.i1.37] [PMID: 33505149]
[4]
Chu, Y.; Shan, X.; Chen, T.; Jiang, M.; Wang, Y.; Wang, Q.; Salahub, D.R.; Xiong, Y.; Wei, D.Q. DTI-MLCD: Predicting drug-target interactions using multi-label learning with community detection method. Brief. Bioinform., 2021, 22(3), bbaa205.
[http://dx.doi.org/10.1093/bib/bbaa205] [PMID: 32964234]
[5]
Lin, S.; Wang, Y.; Zhang, L.; Chu, Y.; Liu, Y.; Fang, Y.; Jiang, M.; Wang, Q.; Zhao, B.; Xiong, Y.; Wei, D.Q. MDF-SA-DDI: Predicting drug–drug interaction events based on multi-source drug fusion, multi-source feature fusion and transformer self-attention mechanism. Brief. Bioinform., 2022, 23(1), bbab421.
[http://dx.doi.org/10.1093/bib/bbab421] [PMID: 34671814]
[6]
Wörheide, M.A.; Krumsiek, J.; Kastenmüller, G.; Arnold, M. Multi-omics integration in biomedical research – A metabolomics-centric review. Anal. Chim. Acta, 2021, 1141, 144-162.
[http://dx.doi.org/10.1016/j.aca.2020.10.038] [PMID: 33248648]
[7]
Heath, J.R.; Ribas, A.; Mischel, P.S. Single-cell analysis tools for drug discovery and development. Nat. Rev. Drug Discov., 2016, 15(3), 204-216.
[http://dx.doi.org/10.1038/nrd.2015.16] [PMID: 26669673]
[8]
Fox, J.T.; Myung, K. Cell-based high-throughput screens for the discovery of chemotherapeutic agents. Oncotarget, 2012, 3(5), 581-585.
[http://dx.doi.org/10.18632/oncotarget.513] [PMID: 22653910]
[9]
Amin, S.; Rattner, J.; Keramati, M.R.; Farshidfar, F.; McNamara, M.G.; Knox, J.J.; Kopciuk, K.; Vogel, H.J.; Bathe, O.F. A strategy for early detection of response to chemotherapy drugs based on treatment-related changes in the metabolome. PLoS One, 2019, 14(4), e0213942.
[http://dx.doi.org/10.1371/journal.pone.0213942] [PMID: 30939138]
[10]
Xu, T.; Zhao, H.; Wang, M.; Chow, A.; Fang, M. Metabolomics and in silico docking-directed discovery of small-molecule enzyme targets. Anal. Chem., 2021, 93(6), 3072-3081.
[http://dx.doi.org/10.1021/acs.analchem.0c03684] [PMID: 33541075]
[11]
Zampieri, M.; Zimmermann, M.; Claassen, M.; Sauer, U. Nontargeted metabolomics reveals the multilevel response to antibiotic perturbations. Cell Rep., 2017, 19(6), 1214-1228.
[http://dx.doi.org/10.1016/j.celrep.2017.04.002] [PMID: 28494870]
[12]
Najm, F.J.; Madhavan, M.; Zaremba, A.; Shick, E.; Karl, R.T.; Factor, D.C.; Miller, T.E.; Nevin, Z.S.; Kantor, C.; Sargent, A.; Quick, K.L.; Schlatzer, D.M.; Tang, H.; Papoian, R.; Brimacombe, K.R.; Shen, M.; Boxer, M.B.; Jadhav, A.; Robinson, A.P.; Podojil, J.R.; Miller, S.D.; Miller, R.H.; Tesar, P.J. Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo. Nature, 2015, 522(7555), 216-220.
[http://dx.doi.org/10.1038/nature14335] [PMID: 25896324]
[13]
Pushpakom, S.; Iorio, F.; Eyers, P.A.; Escott, K.J.; Hopper, S.; Wells, A.; Doig, A.; Guilliams, T.; Latimer, J.; McNamee, C.; Norris, A.; Sanseau, P.; Cavalla, D.; Pirmohamed, M. Drug repurposing: Progress, challenges and recommendations. Nat. Rev. Drug Discov., 2019, 18(1), 41-58.
[http://dx.doi.org/10.1038/nrd.2018.168] [PMID: 30310233]
[14]
Wages, P.A.; Kim, H.Y.H.; Korade, Z.; Porter, N.A. Identification and characterization of prescription drugs that change levels of 7-dehydrocholesterol and desmosterol. J. Lipid Res., 2018, 59(10), 1916-1926.
[http://dx.doi.org/10.1194/jlr.M086991] [PMID: 30087204]
[15]
Geeraerts, S.L.; Kampen, K.R.; Rinaldi, G.; Gupta, P.; Planque, M.; Louros, N.; Heylen, E.; De Cremer, K.; De Brucker, K.; Vereecke, S.; Verbelen, B.; Vermeersch, P.; Schymkowitz, J.; Rousseau, F.; Cassiman, D.; Fendt, S.M.; Voet, A.; Cammue, B.P.A.; Thevissen, K.; De Keersmaecker, K. Repurposing the antidepressant sertraline as SHMT inhibitor to suppress serine/glycine synthesis-addicted breast tumor growth. Cancer Ther., 2021, 20(1), 50-63.
[http://dx.doi.org/10.1158/1535-7163.MCT-20-0480] [PMID: 33203732]

Rights & Permissions Print Cite
© 2025 Bentham Science Publishers | Privacy Policy